Primary multidrug-resistant leprosy, United States

Emerging Infectious Diseases

Volumn 19, Issue 1, 2013, Pages 179-180

  Williams, Diana Lynn ^a,b   Hagino, Timothy ^c   Sharma, Rahul ^a,b   Scollard, David ^a,b  

^a Health Resources and Services Administration   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; DAPSONE; HEMOSIDERIN; MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; CASE REPORT; ELECTROPHORESIS; HAND INJURY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LEPROMATOUS LEPROSY; LEPROSY; LETTER; MALE; MUTATION; MYCOBACTERIUM LEPRAE; PAPULE; PRURITUS; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; SKIN DEFECT; TRANSDERMAL PATCH; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MUTATION; MYCOBACTERIUM LEPRAE; NEGLECTED DISEASES; RECURRENCE; TRANSIENTS AND MIGRANTS; UNITED STATES;

EID: 84871630435     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1901.120864     Document Type: Letter

References (10)

1. Scollard DM, Adams LB, Gillis TP, Kra-henbuhl JL, Tniman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338-81. http://dx.doi.org/10.1128/CMR. 19.2.338381.2006
2. World Health Organization. Surveillance of drag resistance in leprosy: 2010. Wkly Epidemiol Rec. 2011;86:237-40.
3. Tniman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, Gillis TP. Enumeration of Mycobacterium leprae using real-time PCR. PLoS Negl Trop Dis. 2008;2:e328. http://dx.doi.org/10.1371 / jounial.pntd.0000328
4. Tniman RW, Singh P, Sharma R, Bus-so P, Rougemont J, Paniz-Mondolfì A, et al. Probable zoonotic leprosy in the southern United States. N Engl J Med. 2011;364:1626-33. http://dx.doi. org/10.1056/NEJMoa 1010536
5. Honoré N, Cole ST. Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob Agents Chemother. 1993;37:414-8. http://dx.doi.Org/10.l 128/ AAC.37.3.414
6. Williams DL, Spring L, Harris E, Roche P, Gillis TP. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. Antimicrob Agents Chemother. 2000;44:1530-7. http://dx.doi. org/10.1128/A AC.44.6.1530-1537.2000
7. Norman G, Joseph G, Richard J. Relapses in multibacillary patients treated with multi-dnig therapy until smear negativity: findings after twenty years. Int J Lepr Other Mycobact Dis. 2004;72:1-7. http:// dx.doi.org/10.1489/1544-5 81 X(2004)072 <0001:RIMPTW>2, O.CO;2
8. Gelber RH, Balagon VF, Cellona RV. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low. Int J Lepr Other Mycobact Dis. 2004:72:493500. http://dx.doi.org/10.1489/1544-581X(2004)72<493:TRRIML>2, O.CO;2
9. Dacso M, Jacobson RR, Slryjcwska BM, Prcsligiacomo J, Scollard DM. Evaluation of multi-drug therapy for leprosy in the USA using daily rifampin. South Med J. 2011;104:689-94. http://dx.doi. org/10.1097/S MJ,0b013c31822d6014
10. Scollard DM, Slryjcwska BM. Leprosy; treatment and prevention. In: Basow DS, editor. UpToDate. Waltham (MA): UpTo-Date; 2011.